Does Cephalothin Inhibit Matrix Metalloproteinases?
A recent paper by Santavirta et al. (5) describes the inhibition by cephalothin of a 2,4-dinitrophenol (DNP)-octapeptidecleaving activity (substrate mimics collagen cleavage site) in tissue around loose hip prostheses. The authors conclude that cephalothin inhibits matrix metalloproteinases (MMPs), a family of zinc-dependent enzymes that degrade all major components of the extracellular matrix (10), in periprosthetic tissue. Interestingly, doxycycline, a known inhibitor of MMPs (7), showed no inhibition in the author's assay.
There are several issues critical to the validity of the conclusions that are not addressed in the paper. First, the synthetic substrate used in the assay is not specific for MMPs. In fact, the original publication on the use of the DNP-octapeptide substrate noted that it is cleaved by several proteinases and cautioned against its use with crude extracts (3). Second, almost all known small molecule inhibitors of MMPs act by chelating the metal at the active site (2) . The previously reported MMP inhibitor cefotetan (6) may also act in a similar manner, through its side chain. No such chelating potential exists for cephalothin. Third, there is extensive literature on the inhibition of serine proteinases, such as elastase, by ␤-lactams (4). Elastase itself, a relatively nonspecific enzyme (1, 8) found in leukocytes and thus probably present in inflamed periprosthetic tissue (9), might hydrolyze the DNP-octapeptide used in the assay.
In view of the above, additional experiments are in order before any conclusions can be drawn. At a minimum, the DNPoctapeptide-cleaving activity in periprosthetic tissue should be characterized with known inhibitors of metallo-(EDTA, 1,10-phenanthroline) and serine (diisopropylfluorophosphate, phenylmethanesulfonyl fluoride, 3,4-dichloroisocoumarin) proteinases. In view of the implied usefulness of cephalothin in disease states characterized by excessive MMP activity, it is important to ascertain whether cephalothin does indeed inhibit MMPs.
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Authors' Reply
We showed that cephalothin inhibited degradation of a synthetic DNP-S peptide mediated by tissue extracts from periprosthetic tissues obtained around loose total hip prosthesis (4).
All synthetic substrates suffer certain limitations to their specificity when complex biological fluids or extracts are to be studied instead of purified enzymes. These same limitations naturally also apply to native components or "substrates" of the extracellular matrix (ECM) as new matrix components, new actions of already known enzymes, and new enzymes are being discovered.
DNP-S contains a Gly-Ile bond, quite like that of, e.g., type I, II or III collagens at Gly-775-Ile (Leu)-776. Under the conditions used for testing other enzymes of the MMP or serine proteinase families, i.e., various neutral endoproteinases, also may (or may not) cleave DNP-S.
Dr. Georgopapadakou suggests that all small molecular inhibitors of MMPs act by chelation of the metal at the active site. Other mechanisms of actions have not by any means been excluded. In fact, many small reactive molecules can destabilize MMPs and thus prevent their action; these molecules include organomercurial molecules (10), gold(I) compounds (1), and reactive oxygen species (5, 11). Second, not all small molecular inhibitors and enzymes have been characterized as to their mechanisms of action. This lack of characterization is in fact one of the great challenges today.
A broad characterization of the cephalothin-sensitive, DNP-S-degradative activity using class-specific inhibitors would have extended our observations further. Dr. Georgopapadakou's statement about elastase may well be valid. Although neutrophils are rare in periprosthetic tissues (2, 3), elastase, uninhibited by ␣ 1 -antitrypsin, is found in periprosthetic tissues around loose total hip prostheses (8) . However, various MMPs are also found in such tissue (7, 9) . We agree that it is premature to link this activity to an MMP, although this may well be the case.
As Dr. Georgopapakou mentioned, we have recently described a subtype-specific inhibitory effect of tetracyclines and their derivatives on purified MMP-1 and MMP-8 (6). However, inhibitory potential observed in vitro using pure enzyme protein and "natural" substrates may not apply in vivo; this seems to be the case when tissue extract from periprosthetic tissues is used as a source of proteinases and DNP-S is used as the substrate peptide. There are several reasons for this, and they relate to the enzyme kinetics, stability of the enzymes, activation mechanisms, competition, substrate profiles, endogenous inhibitors, and many other factors. Our observation on cephalothin-mediated inhibition under these circumstances is of obvious relevance, because it demonstrates that this proteo-lytic activity can be inhibited by cephalothin, a Food and Drug Administration-approved and registered antibiotic drug, at concentrations easily achieved during regular treatment.
